期刊文献+

Study on the Relationship between P-glycoprotein and CD44 Expression in Gastric Carcinoma 被引量:3

Study on the Relationship between P-glycoprotein and CD44 Expression in Gastric Carcinoma
下载PDF
导出
摘要 客观:在 P-glycoprotein (P-gp ) 和象他们在胃的癌的临床的意义一样的粘附分子 CD44 之间的关系的调查。方法:Toexamine 在有由流动 cytometryand 的胃的癌的 98 种情况中的 P-gp 和 CD44 的表示水平与 clinicopathological 因素评估他们的关系。结果:在 98 胃的癌之中, 40 个盒子(40.8%) 是 P-gp negative (积极房间 【 25%) ;P-gp 积极房间的 14 盒子(14.2%)were25%-40% 表示;17 个盒子(17.3%) 是 P-gp 积极房间的 41%-60% 表示;27 个盒子(27.5%) 是高表示(积极房间 】 60%) 在有胃的癌的所有病人的 P-gp。当肿瘤尺寸是超过 6 厘米时, CD44 积极的 P-gp 显示出有效差量(P 【 0.05 ) 在有 P-gp 的 35 种情况中积极,与它相比在 24 情况 withP-gp negative。当肿瘤在低中等的区分的胃的癌时, CD44 的表示显示出有效差量(P 【 0.05 ) 在有 P-gp 的 44 种情况中积极,作为与它相比在有 P-gp 的 30 种情况中否定。当病人在临床的Ⅲ - Ⅳ舞台时, CD44 的表示显示出有效差量(P 【 0.05 ) 在有 P-gp 的 42 种情况中积极,作为与它相比在有 P-gp 的 30 种情况中否定。什么时候有淋巴节点转移的病人, theirCD44 表示显示出有效差量(P 【 0.05 ) 在有 P-gp 的 46 种情况中积极,与它相比在有 P-gp 的 32 种情况中否定。肿瘤 P-gp 什么时候表示了积极,他们的 CD44expression 将是增加。结论:当 CD44 和 P-gp 两个都有积极高表示时,它将显著地与胃的癌前进和转移被联系因此两个是在胃的癌的积极表情,它可能建议差、相反的预后结果。 Objective: Investigation of the relationship between P-glycoprotein (P-gp) and adhesion molecule CD44 as well as their clinical significance in gastric carcinoma. Methods: To examine the expressed level of P-gp and CD44 in 98 cases with gastric carcinoma by flow eytometry and evaluate their relationships with elinieopathologieal factors. Results: Among the 98 gastric carcinomas, 40 cases (40.8%) were P-gp negative (positive cells 〈25%); 14 cases (14.2%) were 25%-40% expression of P-gp positive cells; 17 cases (17.3%) were 41%-60% expression of P-gp positive cells; 27 cases (27.5%) were the high expression (positive cells 〉60%) of P-gp in all patients with gastric carcinoma. When the tumor sizes were more than 6 cm, the P-gp positive of CD44 showed a significant difference (P〈0.05) in 35 cases with P-gp positive, compared with it in 24 cases with P-gp negative. When the tumors were in low-moderate differentiated gastric carcinoma, the expression of CD44 showed a significant difference (P〈0.05) in 44 cases with P-gp positive, as compared with it in 30 cases with P-gp negative. When the patients were in clinical Ⅲ-Ⅳ stage, the expression of CD44 showed a significant difference (P〈0.05) in 42 cases with P-gp positive, as compared with it in 30 cases with P-gp negative. When the patients with lymph node metastasis, their CD44 expression showed a significant difference (P〈0.05) in 46 cases with P-gp positive, compared with it in 32 cases with P-gp negative. When the tumors P-gp expressed positive, their CD44 expression will be increase. Conclusion: When the CD44 and P-gp both have the positive high expression, it will be significantly associated with the gastric carcinoma progression and metastasis, so both were a positive expression in gastric carcinoma, it might suggest a poor and unfavorable prognosis result.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第4期253-256,共4页 中德临床肿瘤学杂志(英文版)
基金 Supported by the ZheJiang Medical and Health Science Foundation (No.2005A09).
关键词 P-醣蛋白 胃癌 基因表达 CD44 gastric carcinoma P-glycoprotein CD44 FCM
  • 相关文献

参考文献4

二级参考文献25

  • 1倪灿荣,戴益民,张松平.肿瘤转移抑制基因nm_(23)蛋白类似物在肝细胞癌中的表达[J].中华医学杂志,1996,76(1):53-55. 被引量:12
  • 2[7]Molinari A,Calcabrini A,Meschini S,et al. What is the relationship between P - glycoprotein and adhesion molecule expression in melanoma cells? Melanoma Res, 2002, 12: 109-114.
  • 3[8]Aloia TA,Harpole DH Jr, Reed CE,et al.Tumor marker expression is predictive of survival in patients with esophageal cancer. Ann Thorac Surg, 2001,72:859 - 866.
  • 4[9]Soslow RA, Slomovitz BM, Saqi A,et al. Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mullerian serous carcinomas: clinical divergence without immunophenotypic differences. Gynecol Oncol, 2000, 79:430 - 437.
  • 5[10]De la Torre M,Heldin P,Bergh J.Expression of the CD44 glycoprotein (lymphocyte - homing receptor) in untreated human breast cancer and its relationship to prognostic markers.Anticancer Res, 1995, 15: 2791 - 2795.
  • 6Roye GD, Myers RB, Brown D, et al. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus[J]. Int J Cancer,1996,69(4): 254-258.
  • 7Castella E, Ariza A, Fernandez-Vasalo A, et al. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma[J]. J Clin Pathol,1996,49(6): 489-492.
  • 8Hori T, Yamashita Y, Ohira M, et al. A novel orthotopic implantation model of human esophageal carcinoma in nude rats: CD44H mediates cancer cell invasion in vitro and in vivo[J]. Int J Cancer,2001,92(4): 489-496.
  • 9Kuryu M, Ozaki T, Nishida K, et al. Expression of CD44 variants in osteosarcoma[J]. J Cancer Res Clin Oncol,1999,125(11): 646-652.
  • 10Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival[J]. J Hepatol,2000,32(1): 78-84.

共引文献15

同被引文献118

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部